Table 1.
Nlrp6 in host defense following microbial infection.
Pathogen | Model used | Phenotype observed | Proposed mechanism of action | Inflammasome/NF-κB/IFN dependent | Refs. |
---|---|---|---|---|---|
Staphylococcus aureus | Pneumonia (IT) | Nlrp6−/− mice protected | Nlrp6 augments pyroptosis and necroptosis of neutrophils and macrophages, thereby reducing the number of phagocytes to clear bacteria. In addition, Nlrp6 deficiency enhances IFN-γ secretion in the lungs | Inflammasome dependent | 12 |
Listeria monocytogens | Systemic infection (IV) | Nlrp6−/− mice protected | Nlrp6 inflammasome enhances IL-18 secretion, which is detrimental during Listeria infection | Inflammasome dependent | 18 |
Salmonella typhimurium | Systemic infection (IV) | No change in phenotype | NA | 18 | |
Salmonella typhimurium | Systemic infection (IP) | Nlrp6−/− mice protected | Nlrp6 deficiency augments NF-κB-mediated neutrophil recruitment, which is important to limit Salmonella | Inflammasome independent, but NF-κB dependent | 13 |
Escherichia coli | Systemic infection (IP) | Nlrp6−/− mice protected | Deletion of Nlrp6 enhances NF-κB-mediated neutrophil recruitment | Inflammasome independent, but NF-κB dependent | 13 |
Clostridium rodentium | Enteritis model | Nlrp6−/− mice susceptible | Nlrp6−/− mice had a thin mucus layer as a result of defective goblet cell function. This facilitates prolonged adherence of C. rodentium | Inflammasome dependent | 11 |
Encephalomyocarditis virus (EMCV), Norovirus | Systemic infection (EMCV: IP and oral; Norovirus: oral) |
Nlrp6−/− mice susceptible | Nlrp6 recognizes cytosolic long dsRNA and activated mitochondrial antiviral signaling proteins (MAVS) to enhance the antiviral response. Nlrp6-Dhx15-MAVs axis augments the expression of interferon-stimulated genes to limit virus in the intestine | Inflammasome independent, but IFN dependent | 36 |